Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Tender Offer

14 Aug 2025 07:00

RNS Number : 2504V
Seed Innovations Limited
14 August 2025
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

14 August 2025

SEED Innovations Limited

("SEED" or the "Company")

 

Launch of Tender Offer to Return Capital to Shareholders

 

SEED Innovations Limited (AIM: SEED), the AIM-quoted investment company, confirms the launch of a Tender Offer to return up to £1.91 million to Eligible Shareholders through the repurchase of up to 86,826,818 Ordinary Shares at a price of 2.2 pence per share.

 

The price of 2.2 pence per share represents a 12.8% premium to the trading price of the Company's shares on AIM at the close of business on 17 July 2025 (the last trading day prior to publication of the Shareholder Circular (referenced below) setting out terms of the proposed Tender Offer) and represents a c.25% premium to the 200-day moving average price (1.77 pence) of the Company's shares. The Board does not consider a shorter VWAP comparison suitable as the VWAP over a shorter period has been materially impacted by announcement on 18 July 2025 of the Tender Offer, changes to the Board, and proposed adoption of the new investing policy.

 

Whilst the Tender Price remains below the Company's current share price, it has not been adjusted from the level first announced on 18 July 2025. The decision reflects the positive market response to the Tender Offer, proposed changes to the Board, and the revised investing policy focusing on robotics and AI.

 

Nevertheless, the Tender Offer provides shareholders who wish to exit an additional liquidity opportunity to do so.

 

The launch of the Tender Offer follows the approval of various resolutions by shareholders at the Company's Annual General Meeting ('AGM') held on 13 August 2025 and forms part of the Board's strategy as set out in the Shareholder Circular dated 18th July 2025.

 

Eligible Shareholders may tender up to 45% of their holding. The Tender Offer is open only to shareholders on the register at 6.00 p.m. on the Record Date of 5 September 2025. Shares purchased under the Tender Offer will be cancelled, resulting in a reduction of the Company's issued share capital.

 

Timetable of Principal Events:

Event

Date

Publication of Circular

14 August 2025

Record Date for Tender Offer

6.00 p.m. on 5 September 2025

Latest time for receipt of Tender Offer acceptances

11.00 a.m. on 5 September 2025

Results of Tender Offer announced

By 8.00 a.m. on 8 September 2025

Settlement (CREST and cheque dispatch)

By 19 September 2025

 

Rationale for the Tender Offer

As outlined in the Tender Offer Circular, the Board continues to believe that the Company's shares trade at a significant and persistent discount to NAV, despite a robust cash position and resilient portfolio performance. With shareholder approval of the new investing policy focused on robotics and artificial intelligence ('AI'), and, subject to regulatory approval, the proposed board appointments detailed in the Notice of AGM, the Company remains confident in SEED's long-term potential.

 

However, the Board recognises that some shareholders may prefer a near-term return of capital. The Tender Offer therefore provides a balanced and timely mechanism to return value to shareholders while preserving sufficient flexibility for the Company to pursue its new strategic direction.

 

Director Participation

Certain Directors, former Directors and significant shareholders, including Mr Jim Mellon and Galloway Limited (a company indirectly wholly owned by Mr Mellon), have provided undertakings not to participate in the Tender Offer, subject to their aggregate interest not exceeding 29.9% of the Company's issued share capital.

 

Important Information

Shareholders who do not wish to participate in the Tender Offer are not required to take any action.

 

This announcement is not a recommendation or invitation to participate in the Tender Offer. Shareholders should read the full terms and conditions set out in the Circular before deciding whether to tender their shares. If in doubt, shareholders should consult their stockbroker, bank manager, solicitor, ‎accountant or other independent financial adviser authorised under the Financial Services and ‎Markets Act 2000, as amended, if they are a resident in the United Kingdom or, if not, from another ‎appropriately authorised financial adviser without delay.‎

 

Further Information

Further information on the background to and terms of the Tender Offer is set out in a circular being posted to shareholders today (the "Circular") and available on the Company's website at:https://seedinnovations.co/investor-centre/aim-rule-26. This is also available by clicking or pasting the following link into your website browser:

http://www.rns-pdf.londonstockexchange.com/rns/2504V_1-2025-8-13.pdf

 

Certain regulatory information is included in Appendix 1 below.

 

ENDS

 

For further information on the Company please visit:www.seedinnovations.co or contact:

 

Lance de Jersey

SEED Innovations Ltd

E:info@seedinnovations.co

James Biddle 

Roland Cornish 

BeaumontCornishLimited, 

Nomad 

T: (0)20 7628 3396

 

Isabella Pierre 

Damon Heath 

Shard Capital Partners LLP 

Broker 

T: (0)20 7186 9927 

Ana Ribeiro

Isabel de Salis

St Brides Partners Ltd, 

Financial PR 

E: seed@stbridespartners.co.uk 

 

Appendix 1

The following information is included for regulatory reason in respect of the Tender Offer

 

Issuer/Company Name 

 Seed Innovations Limited

Security/Securities 

 Ordinary Shares of 1p each

ISIN(s) 

 GG00BRK9BQ81

TIDM(s) 

 SEED

Tender Offer opened 

 14 August 2025

Tender Price 

 2.2pence

Currency of Tender Price (eg GBP / USD) 

 GBP

Record Date 

 6.00pm 5 September 2025

Last day for receipt of Tender elections 

 11.00am 5 September 2025

Calculation Date (if applicable) 

 N/A

Date of General Meeting 

 13 August 2025

Settlement of Tender Consideration (Pay Date) 

 By 19 September 2025

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENPKNBDOBKDNFD
Date   Source Headline
7th May 20267:00 amRNSInvestment in Feather Robotics, Inc.
1st May 20267:00 amRNS-RInvestee Company Update: Little Green Pharma
15th Apr 20267:00 amRNS-RInvestor Presentation
14th Apr 20267:00 amRNSInvestment in Clean Food Group Funding Round
23rd Feb 20262:47 pmRNS-RInvestor Presentation Update
11th Feb 20267:00 amRNS-RInvestor Presentation
14th Jan 20262:46 pmRNSInvestee Company Update: Little Green Pharma
9th Jan 20263:19 pmRNSDirector's Dealing
23rd Dec 20257:00 amRNSAppointment of Specialist Investment Consultant
23rd Dec 20257:00 amRNSAppointment of Specialist Investment Consultant
10th Dec 202510:49 amRNS-RInvestor Presentation Postponed
8th Dec 20252:30 pmRNS-RIntroduction to Newly Appointed Directors
4th Dec 20257:00 amRNSInterim Results
26th Nov 20257:00 amRNSBoard Appointments
13th Nov 202510:07 amRNS-RInvestee Company Update: Little Green Pharma Ltd
25th Sep 20257:00 amRNS-RInvestee Company Update: Clean Food Group
18th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 20257:00 amRNSHolding(s) in Company
10th Sep 20259:11 amRNSHolding(s) in Company
8th Sep 202511:01 amRNSResult of Tender Offer
14th Aug 20257:00 amRNSDirectorship Changes
14th Aug 20257:00 amRNSTender Offer
13th Aug 20253:09 pmRNSResult of AGM
5th Aug 20251:39 pmRNSHolding(s) in Company
1st Aug 202510:55 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSNotice of AGM & Publication of Circular
18th Jul 20257:00 amRNSInvestee Company Update: Little Green Pharma Ltd
17th Jul 20257:00 amRNSDivestment of Oxford BioDynamics Position
20th Jun 20257:00 amRNSFinal Results
30th May 20252:33 pmRNS-RInvestee Company Update: Little Green Pharma Ltd
28th May 20258:03 amRNSHolding(s) in Company
23rd May 20257:41 amRNSHolding(s) in Company
22nd May 20257:00 amRNSInvestee Company Update: Juvenescence Ltd
30th Apr 202512:13 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Apr 202510:48 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSHolding(s) in Company
7th Apr 20251:35 pmRNSHolding(s) in Company
28th Mar 20257:00 amRNS-RNew Corporate Presentation
25th Feb 20253:08 pmRNSHolding(s) in Company
5th Feb 202510:44 amRNSInvestee Company Update: Little Green Pharma Ltd
31st Jan 20251:02 pmRNSHolding(s) in Company
31st Jan 202512:38 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20257:00 amRNS-R2025 New Year Statement
20th Dec 20242:19 pmRNS-RInvestee Company Update: Little Green Pharma Ltd
10th Dec 20247:07 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSHalf-year Report
11th Nov 202412:43 pmRNSPortfolio Update
17th Oct 202412:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Oct 20247:24 amRNSPortfolio Update
24th Sep 20247:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.